Bevacizumab Lyophilized powder 5 mg
Bevacizumab Lyophilized powder (CAS 216974-75-3) is a research compound from TOKU-E, supplied as 5 mg. Purity (HPLC): ≥98.0%. Typical use: cancer research. Store at -20 °C.
| CAS number | 216974-75-3 |
|---|---|
| Molecular Formula | C6638H10160N1720O2108S44 |
| Molecular Weight | 149146,82 g/mol |
| Purity | (HPLC): ≥98.0% |
| Applications | Cancer research |
| Documentation | Certificate of Analysis available on request |
| Manufacturer | TOKU-E |
| MPN | B077 |
| Item number | B077-5MG |
| Pack Size | 5 mg |
| Lead Time | ~7 days |
| Availability | Supplier-sourced |
| Country of Origin | China |
| Storage Temperature | -20°C |
| Shipping Temperature | ambient |
Bevacizumab Lyophilized powder 5 mg is supplied by Lancetech Limited as an authorised UK distributor for TOKU-E. Typical use: cancer research.
Product details
- CAS number: 216974-75-3
- Molecular formula: C6638H10160N1720O2108S44
- Molecular weight: 149146,82 g/mol
- Purity: (HPLC): ≥98.0%
- Pack size: 5 mg
- Storage: -20°C
- Shipping condition: ambient
- Country of origin: China
- Certificate of Analysis available on request
Manufactured by TOKU-E Company, Bellingham, Washington, USA — a specialist producer of antibiotics, antifungals and bioactive small molecules for research and quality control. Supplied in the United Kingdom by Lancetech Limited.
Product documents
Documents are available to registered customers. Sign in or create a free account — it takes a minute.
Shipping & safety
Frequently bought together
More Certified Reference Standards from TOKU-E.
Actinomycin D, 5 mg
Actinomycin D, 10 mg
Actinomycin D, 25 mg
Amikacin 1g
Browse more:TOKU-E Certified Reference StandardsAll TOKU-E productsAll Certified Reference Standards